308 related articles for article (PubMed ID: 16819406)
1. The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response.
Elitsur N; Lorenz JN; Hawkins JA; Rudolph JA; Witte D; Yang LE; McDonough AA; Cohen MB
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S74-81. PubMed ID: 16819406
[TBL] [Abstract][Full Text] [Related]
2. Cellular effects of guanylin and uroguanylin.
Sindić A; Schlatter E
J Am Soc Nephrol; 2006 Mar; 17(3):607-16. PubMed ID: 16382016
[TBL] [Abstract][Full Text] [Related]
3. Guanylin and related peptides.
Bełtowski J
J Physiol Pharmacol; 2001 Sep; 52(3):351-75. PubMed ID: 11596856
[TBL] [Abstract][Full Text] [Related]
4. Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity.
Forte LR; Fan X; Hamra FK
Am J Kidney Dis; 1996 Aug; 28(2):296-304. PubMed ID: 8768930
[TBL] [Abstract][Full Text] [Related]
5. High salt intake increases uroguanylin expression in mouse kidney.
Potthast R; Ehler E; Scheving LA; Sindic A; Schlatter E; Kuhn M
Endocrinology; 2001 Jul; 142(7):3087-97. PubMed ID: 11416031
[TBL] [Abstract][Full Text] [Related]
6. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney.
Santos-Neto MS; Carvalho AF; Monteiro HS; Forte LR; Fonteles MC
Regul Pept; 2006 Sep; 136(1-3):14-22. PubMed ID: 16814407
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of uroguanylin and guanylin in vivo.
Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
[TBL] [Abstract][Full Text] [Related]
8. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
[TBL] [Abstract][Full Text] [Related]
9. Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load.
Lorenz JN; Nieman M; Sabo J; Sanford LP; Hawkins JA; Elitsur N; Gawenis LR; Clarke LL; Cohen MB
J Clin Invest; 2003 Oct; 112(8):1244-54. PubMed ID: 14561709
[TBL] [Abstract][Full Text] [Related]
10. Renal electrolyte effects of guanylin and uroguanylin.
Sindić A; Schlatter E
Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):10-5. PubMed ID: 17143065
[TBL] [Abstract][Full Text] [Related]
11. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
Forte LR
Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
[TBL] [Abstract][Full Text] [Related]
12. Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells.
Sindiće A; Başoglu C; Cerçi A; Hirsch JR; Potthast R; Kuhn M; Ghanekar Y; Visweswariah SS; Schlatter E
J Biol Chem; 2002 May; 277(20):17758-64. PubMed ID: 11889121
[TBL] [Abstract][Full Text] [Related]
13. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Carrithers SL; Ott CE; Hill MJ; Johnson BR; Cai W; Chang JJ; Shah RG; Sun C; Mann EA; Fonteles MC; Forte LR; Jackson BA; Giannella RA; Greenberg RN
Kidney Int; 2004 Jan; 65(1):40-53. PubMed ID: 14675035
[TBL] [Abstract][Full Text] [Related]
14. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives.
Fonteles MC; do Nascimento NR
Can J Physiol Pharmacol; 2011 Aug; 89(8):575-85. PubMed ID: 21815750
[TBL] [Abstract][Full Text] [Related]
15. Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.
Forte LR
Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
[TBL] [Abstract][Full Text] [Related]
16. E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.
Giannella RA; Mann EA
Trans Am Clin Climatol Assoc; 2003; 114():67-85; discussion 85-6. PubMed ID: 12813912
[TBL] [Abstract][Full Text] [Related]
17. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
18. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
[TBL] [Abstract][Full Text] [Related]
19. Guanylin peptides: cyclic GMP signaling mechanisms.
Forte LR; Freeman RH; Krause WJ; London RM
Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
[TBL] [Abstract][Full Text] [Related]
20. High-salt intake primes the rat kidney to respond to a subthreshold uroguanylin dose during ex vivo renal perfusion.
Fonteles MC; Havt A; Prata RB; Prata PH; Monteiro HS; Lima AA; Jorge AR; Santos CF; Greenberg RN; Nascimento NR
Regul Pept; 2009 Nov; 158(1-3):6-13. PubMed ID: 19632278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
